Iatrogenix Launches Companion Support Model for Neurological Care

New company aims to address gap between clinical efficacy and real-world persistence of neurological treatments

Published on Feb. 15, 2026

Got story updates? Submit your updates here. ›

Iatrogenix, a clinician-founded company, has launched a structured model designed to support patients with neurological conditions as they navigate the functional demands of treatment in their daily lives between clinical appointments. The company's approach aims to address the disconnect between clinical efficacy and real-world persistence that is well documented across chronic care, particularly in neurology, where patients often disengage from appropriate medical treatment due to the unsustainable experience of living with those interventions.

Why it matters

The breakdown in patient engagement rarely occurs during clinical encounters, but rather unfolds in the weeks and months between appointments, when patients are left to manage complex physiological experiences independently. This can lead to premature discontinuation of treatments, strained therapeutic relationships, and an unnecessary cycling through interventions, undermining the durability of otherwise appropriate medical care.

The details

Iatrogenix's programs are not intended to treat medication side effects or replace prescribed therapies, but rather to provide condition-focused education and support structures that help patients tolerate care long enough for outcomes to develop. The company's approach emphasizes education and scaffolding to reduce uncertainty and help patients interpret symptoms, with scientific oversight provided by a board-certified physician with fellowship training in headache neurology.

  • Iatrogenix launched its initial programs focused on migraine and mental clarity support in February 2026.

The players

Iatrogenix

A clinician-founded company that has developed a structured model to support patients with neurological conditions as they navigate the functional demands of treatment in their daily lives between clinical appointments.

Dr. Nicholas Tzikas

A board-certified physician with fellowship training in headache neurology who has co-directed a university-based headache and facial pain program and provides scientific oversight for Iatrogenix's programs.

Got photos? Submit your photos here. ›

What they’re saying

“Patients often disengage from appropriate medical treatment not because interventions fail clinically, but because the experience of living with those interventions becomes unsustainable in daily life.”

— Dr. Nicholas Tzikas, Board-certified physician with fellowship training in headache neurology

“When treatments are abandoned prematurely, clinicians interpret incomplete trials as failure, plans are modified prematurely, and patients cycle through interventions unnecessarily. The collaborative trust that sustains care weakens, and what appears to be therapeutic failure often reflects insufficient infrastructure surrounding treatment.”

— Dr. Nicholas Tzikas, Board-certified physician with fellowship training in headache neurology

What’s next

Iatrogenix plans to expand its support programs to additional neurological conditions where physiological shifts related to treatment may undermine long-term engagement if unsupported.

The takeaway

Iatrogenix's approach highlights the need for healthcare providers to invest in infrastructure that supports the lived patient experience between clinical encounters, in order to improve the durability of appropriate medical interventions and strengthen the therapeutic relationship.